These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

790 related articles for article (PubMed ID: 33150359)

  • 21. Distinct subthalamic coupling in the ON state describes motor performance in Parkinson's disease.
    Ozturk M; Abosch A; Francis D; Wu J; Jimenez-Shahed J; Ince NF
    Mov Disord; 2020 Jan; 35(1):91-100. PubMed ID: 31348550
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Brain networks modulated by subthalamic nucleus deep brain stimulation.
    Accolla EA; Herrojo Ruiz M; Horn A; Schneider GH; Schmitz-Hübsch T; Draganski B; Kühn AA
    Brain; 2016 Sep; 139(Pt 9):2503-15. PubMed ID: 27412387
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synchronised spiking activity underlies phase amplitude coupling in the subthalamic nucleus of Parkinson's disease patients.
    Meidahl AC; Moll CKE; van Wijk BCM; Gulberti A; Tinkhauser G; Westphal M; Engel AK; Hamel W; Brown P; Sharott A
    Neurobiol Dis; 2019 Jul; 127():101-113. PubMed ID: 30753889
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Subthalamic deep brain stimulation induces finely-tuned gamma oscillations in the absence of levodopa.
    Wiest C; Tinkhauser G; Pogosyan A; He S; Baig F; Morgante F; Mostofi A; Pereira EA; Tan H; Brown P; Torrecillos F
    Neurobiol Dis; 2021 May; 152():105287. PubMed ID: 33549721
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phase-Dependent Suppression of Beta Oscillations in Parkinson's Disease Patients.
    Holt AB; Kormann E; Gulberti A; Pötter-Nerger M; McNamara CG; Cagnan H; Baaske MK; Little S; Köppen JA; Buhmann C; Westphal M; Gerloff C; Engel AK; Brown P; Hamel W; Moll CKE; Sharott A
    J Neurosci; 2019 Feb; 39(6):1119-1134. PubMed ID: 30552179
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Levodopa reinstates connectivity from prefrontal to premotor cortex during externally paced movement in Parkinson's disease.
    Herz DM; Siebner HR; Hulme OJ; Florin E; Christensen MS; Timmermann L
    Neuroimage; 2014 Apr; 90():15-23. PubMed ID: 24269570
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Coupling between beta and high-frequency activity in the human subthalamic nucleus may be a pathophysiological mechanism in Parkinson's disease.
    López-Azcárate J; Tainta M; Rodríguez-Oroz MC; Valencia M; González R; Guridi J; Iriarte J; Obeso JA; Artieda J; Alegre M
    J Neurosci; 2010 May; 30(19):6667-77. PubMed ID: 20463229
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Spatio-temporal dynamics of cortical drive to human subthalamic nucleus neurons in Parkinson's disease.
    Sharott A; Gulberti A; Hamel W; Köppen JA; Münchau A; Buhmann C; Pötter-Nerger M; Westphal M; Gerloff C; Moll CKE; Engel AK
    Neurobiol Dis; 2018 Apr; 112():49-62. PubMed ID: 29307661
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased SMA-M1 coherence in Parkinson's disease - Pathophysiology or compensation?
    Pollok B; Kamp D; Butz M; Wojtecki L; Timmermann L; Südmeyer M; Krause V; Schnitzler A
    Exp Neurol; 2013 Sep; 247():178-81. PubMed ID: 23664959
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sevoflurane and Parkinson's Disease: Subthalamic Nucleus Neuronal Activity and Clinical Outcome of Deep Brain Stimulation.
    Tsai ST; Tseng GF; Kuo CC; Chen TY; Chen SY
    Anesthesiology; 2020 May; 132(5):1034-1044. PubMed ID: 32044799
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical and cerebral activity changes induced by subthalamic nucleus stimulation in advanced Parkinson's disease: a prospective case-control study.
    Cilia R; Marotta G; Landi A; Isaias IU; Mariani CB; Vergani F; Benti R; Sganzerla E; Pezzoli G; Antonini A
    Clin Neurol Neurosurg; 2009 Feb; 111(2):140-6. PubMed ID: 18995954
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human subthalamic oscillatory dynamics following somatosensory stimulation.
    Elben S; Trenado C; Vesper J; Schnitzler A; Wojtecki L
    Clin Neurophysiol; 2018 Jan; 129(1):79-88. PubMed ID: 29161621
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Local field potential activity dynamics in response to deep brain stimulation of the subthalamic nucleus in Parkinson's disease.
    Wiest C; Tinkhauser G; Pogosyan A; Bange M; Muthuraman M; Groppa S; Baig F; Mostofi A; Pereira EA; Tan H; Brown P; Torrecillos F
    Neurobiol Dis; 2020 Sep; 143():105019. PubMed ID: 32681881
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dopamine replacement modulates oscillatory coupling between premotor and motor cortical areas in Parkinson's disease.
    Herz DM; Florin E; Christensen MS; Reck C; Barbe MT; Tscheuschler MK; Tittgemeyer M; Siebner HR; Timmermann L
    Cereb Cortex; 2014 Nov; 24(11):2873-83. PubMed ID: 23733911
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High density microelectrode recording predicts span of therapeutic tissue activation volumes in subthalamic deep brain stimulation for Parkinson disease.
    Lu CW; Malaga KA; Chou KL; Chestek CA; Patil PG
    Brain Stimul; 2020; 13(2):412-419. PubMed ID: 31866492
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chronic deep brain stimulation reduces cortical β-γ phase amplitude-coupling in patients with Parkinson's disease.
    Eguchi K; Shirai S; Matsushima M; Kano T; Ichikawa T; Yamazaki K; Hamauchi S; Sasamori T; Seki T; Kitagawa M; Shiraishi H; Houkin K; Sasaki H; Yabe I
    Parkinsonism Relat Disord; 2021 Aug; 89():148-150. PubMed ID: 34303200
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adaptive grip force is modulated by subthalamic beta activity in Parkinson's disease patients.
    Imbach LL; Baumann-Vogel H; Baumann CR; Sürücü O; Hermsdörfer J; Sarnthein J
    Neuroimage Clin; 2015; 9():450-7. PubMed ID: 26594627
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Parkinson's disease uncovers an underlying sensitivity of subthalamic nucleus neurons to beta-frequency cortical input in vivo.
    Baaske MK; Kormann E; Holt AB; Gulberti A; McNamara CG; Pötter-Nerger M; Westphal M; Engel AK; Hamel W; Brown P; Moll CKE; Sharott A
    Neurobiol Dis; 2020 Dec; 146():105119. PubMed ID: 32991998
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Encoding of sequence boundaries in the subthalamic nucleus of patients with Parkinson's disease.
    Herrojo Ruiz M; Rusconi M; Brücke C; Haynes JD; Schönecker T; Kühn AA
    Brain; 2014 Oct; 137(Pt 10):2715-30. PubMed ID: 25031238
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Subthalamic oscillatory activities at beta or higher frequency do not change after high-frequency DBS in Parkinson's disease.
    Foffani G; Ardolino G; Egidi M; Caputo E; Bossi B; Priori A
    Brain Res Bull; 2006 Mar; 69(2):123-30. PubMed ID: 16533660
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 40.